Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 48: 1565-1570, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamanishi, H.
Right arrow Articles by Iwatani, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamanishi, H.
Right arrow Articles by Iwatani, Y.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Nutrition
Right arrow Proteomics and Protein Markers
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2002;48:1565-1570.)
© 2002 American Association for Clinical Chemistry, Inc.

Modification of Fully Automated Total Iron-binding Capacity (TIBC) Assay in Serum and Comparison with Dimension TIBC Method

Hachiro Yamanishi1,3a, Shigeru Iyama3, Yoshihisa Yamaguchi3, Yuzuru Kanakura3 and Yoshinori Iwatani1,2

1 Division of Laboratory Science, Course of Health Science, Graduate School of Medicine, and
2 Department of Clinical Laboratory Science, School of Allied Health Sciences, Faculty of Medicine, Osaka University, 1-7 Yamada-oka, Suita, Osaka 565-0871, Japan.

3 Laboratory for Clinical Investigation, Osaka University Hospital, 2-15 Yamada-oka, Suita, Osaka 565-0871, Japan.

aAddress correspondence to this author at: Laboratory for Clinical Investigation, Osaka University Hospital, 2-15 Yamada-oka, Suita, Osaka 565-0871, Japan. Fax 81-6-6879-6635; e-mail yamaha{at}hp-lab.med.osaka-u.ac.jp.

Background: We previously reported the development of a fully automated assay for total iron-binding capacity (TIBC) in serum, using a multipurpose automated analyzer. However, this method requires four different reagents and is thus useful only with a limited number of available analyzers. We simplified our original assay and compared the analytical performance of the modified method with that of a commercial, fully automated TIBC assay (Dimension® TIBC assay).

Methods: We simplified our original method to require only three reagents. Calibration was also altered and was performed with human transferrin standard solutions. An advantage of this method is that it does not require separation of excess unbound iron after the first step of transferrin saturation. Unbound iron is eliminated by formation of a complex with the chromogenic reagent ferrozine in the second step. Iron dissociated from transferrin by acidic pH reacts with ferrozine to form a colored complex in the final step, and the increase in absorbance at 570/660 nm is directly proportional to the TIBC measured. TIBC values were determined for 49 healthy individuals and 148 patients with this modified TIBC assay and with a commercial, fully automated TIBC method (Dimension clinical chemistry system), and calculation of TIBC based on the sum of the serum iron and unsaturated iron-binding capacity was performed for 97 patients.

Results: The within-run CVs for the modified TIBC assay and the Dimension TIBC assay were <4.8% and <2.4%, and the between-run CVs were 1.2% and 1.7%, respectively. The dilution curves were linear for TIBC values up to at least 180 µmol/L with both methods. TIBC values obtained by our method were linearly correlated with serum transferrin concentrations (r = 0.984; Sy|x = 3.18 µmol/L; P <0.001). The correlation between the values obtained with the present method (y) and those obtained with the Dimension TIBC method (x) was y = 1.04x + 1.19 µmol/L (r = 0.985; Sy|x = 2.47 µmol/L), and with the calculation method (x) was y = 1.18x + 2.62 µmol/L (r = 0.976; Sy|x = 3.27 µmol/L).

Conclusions: Our modified, fully automated TIBC assay performed similarly to the Dimension TIBC assay and is adaptable for use with many multipurpose automated analyzers.




The following articles in journals at HighWire Press have cited this article:


Home page
Behav EcolHome page
M. D. Shawkey, K. L. Kosciuch, M. Liu, F. C. Rohwer, E. R. Loos, J. M. Wang, and S. R. Beissinger
Do birds differentially distribute antimicrobial proteins within clutches of eggs?
Behav. Ecol., July 1, 2008; 19(4): 920 - 927.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
H. Yamanishi, S. Iyama, Y. Yamaguchi, Y. Kanakura, and Y. Iwatani
Modification of the Colorimetric Assay for Serum Unsaturated Iron-binding Capacity
Clin. Chem., June 1, 2003; 49(6): 1023 - 1025.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
H. Yamanishi, S. Iyama, Y. Yamaguchi, Y. Kanakura, and Y. Iwatani
Total Iron-binding Capacity Calculated from Serum Transferrin Concentration or Serum Iron Concentration and Unsaturated Iron-binding Capacity
Clin. Chem., January 1, 2003; 49(1): 175 - 178.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.